CARDIOVASCULAR
hamburger

The Cormica Trial Provided Promising Results For Successful Treatment of CMD

Microvascular angina and vasospastic angina are the two most common causes of INOCA, and both types of angina can be identified with diagnostic testing. The randomized CorMicA trial provides a diagnostic and treatment approach.1

The trial protocol assessed patients to determine:

CorMicA Trial: 1-Year RCT Outcomes
CorMicA Trial: 1-Year RCT Outcomes1

Image adapted from Ford et al, J Am Coll Cardiol Intv 20201

Key Cormica Findings
Javier Escaned, MD, PhD, Madrid, Spain

Treatment Trends
Morton J. Kern, MD, California, USA

The CorMicA results indicate a role for a more thorough investigation of coronary microvascular dysfunction among patients with INOCA, as well as an opportunity to better tailor patient treatment.1

INOCA Patient Management

microvasculature is not viewed on angiogram

Kunadian et al. European Heart Journal. 2020; 0:1-21.

References

  1. Ford TJ, Stanley B, Sidik N, et al. 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). J Am Coll Cardiol Intv. 2020;13:33-45.
  2. Knuuti J, Wijns W, Saraste A, et al., for the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407-477. doi:10.1093/eurheartj/ehz425.
  3. Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol. 2018;72:2841-2855.
Important Safety Information

MAT-2006712 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.